Browsing by Author Garcia-De La Torre, I.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 26  next >
Issue DateTitleAuthor(s)
2009A functional Ser413/Ser413 PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosusPalafox-Senchez, C.A.; Vezquez-Del Mercado, M.; Orozco-Barocio, G.; Garcia-De La Torre, I.; Torres-Carrillo, N.; Torres-Carrillo, N.M.; Illades-Aguiar, B.; Munoz-Valle, J.F.; Palafox-Sénchez, C.A., Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biología Molecular y Genómica, University of Guadalajara, Jalisco, Mexico; Vézquez-Del Mercado, M., Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biología Molecular y Genómica, University of Guadalajara, Jalisco, Mexico; Orozco-Barocio, G., Departamento de Inmunología y Reumatología, Hospital General de Occidente, Secretaría de Salud Jalisco, Zapopan, Jalisco, Mexico; García-De La Torre, I., Departamento de Inmunología y Reumatología, Hospital General de Occidente, Secretaría de Salud Jalisco, Zapopan, Jalisco, Mexico; Torres-Carrillo, N., Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biología Molecular y Genómica, University of Guadalajara, Jalisco, Mexico; Torres-Carrillo, N.M., Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biología Molecular y Genómica, University of Guadalajara, Jalisco, Mexico; Illades-Aguiar, B., Laboratorio de Biomedicina Molecular, Unidad Académica de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, Mexico; Muñoz-Valle, J.F., Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biología Molecular y Genómica, University of Guadalajara, Jalisco, Mexico, Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, PO Box 2-207, Guadalajara, Jalisco 44340, Mexico
2009A functional Ser413/Ser413 PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosusPalafox-Senchez, C.A.; Vezquez-Del Mercado, M.; Orozco-Barocio, G.; Garcia-De La Torre, I.; Torres-Carrillo, N.; Torres-Carrillo, N.M.; Illades-Aguiar, B.; Munoz-Valle, J.F.; Palafox-S�nchez, C.A., Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, University of Guadalajara, Jalisco, Mexico; V�zquez-Del Mercado, M., Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, University of Guadalajara, Jalisco, Mexico; Orozco-Barocio, G., Departamento de Inmunolog�a y Reumatolog�a, Hospital General de Occidente, Secretar�a de Salud Jalisco, Zapopan, Jalisco, Mexico; Garc�a-De La Torre, I., Departamento de Inmunolog�a y Reumatolog�a, Hospital General de Occidente, Secretar�a de Salud Jalisco, Zapopan, Jalisco, Mexico; Torres-Carrillo, N., Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, University of Guadalajara, Jalisco, Mexico; Torres-Carrillo, N.M., Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, University of Guadalajara, Jalisco, Mexico; Illades-Aguiar, B., Laboratorio de Biomedicina Molecular, Unidad Acad�mica de Ciencias Qu�mico Biol�gicas, Universidad Aut�noma de Guerrero, Chilpancingo, Guerrero, Mexico; Mu�oz-Valle, J.F., Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, University of Guadalajara, Jalisco, Mexico, Instituto de Investigacion en Reumatologia y Del Sistema Musculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, Centro Universitario de Ciencias de la Salud, PO Box 2-207, Guadalajara, Jalisco 44340, Mexico
2003Advances in the management of septic arthritisGarcia-De La Torre, I.; García-De La Torre, I., Department of Immunology, Hosp. Gen. Occidente Secret. Salud, Justo Sierra #2821, Guadalajara, Jalisco 44690, Mexico, Ctr. Univ. de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
2006Advances in the Management of Septic ArthritisGarcia-De La Torre, I.; García-De La Torre, I., Department of Immunology and Rheumatology, Hospital General de Occidente, Secretaría de Salud, Justo Sierra 2821, Guadalajara, Jalisco C.P. 44690, Mexico, Department of Immunology and Rheumatology, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco 44690, Mexico
1998Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathyRider, L.G.; Gurley, R.C.; Pandey, J.P.; Garcia-De La Torre, I.; Kalovidouris, A.E.; O'Hanlon, T.P.; Love, L.A.; Hennekam, R.C.M.; Baumbach, L.L.; Neville, H.E.; Garcia, C.A.; Klingman, J.; Gibbs, M.; Weisman, M.H.; Targoff, I.N.; Miller, F.W.; Rider, L.G., Ctr. for Biologics Eval. and Res., FDA, Natl. Inst. Arthr. Musculoskel. S., Bethesda, MD, United States, Division of Monoclonal Antibodies, Ctr. for Biologies Eval. and Res., Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892, United States; Gurley, R.C., Ctr. for Biologics Eval. and Res., FDA, Bethesda, MD, United States; Pandey, J.P., Medical University of South Carolina, Charleston, SC, United States; Garcia-De La Torre, I., University of Guadalajara, Hosp. General de Occidente de la SS, Guadalajara, Mexico; Kalovidouris, A.E., Indiana University, VA Medical Center, Indianapolis, IN, United States; O'Hanlon, T.P., Ctr. for Biologics Eval. and Res., FDA, Bethesda, MD, United States; Love, L.A., Ctr. for Food and Spec. Nutritionals, FDA, Washington, DC, United States, Natl. Inst. Arthr. Musculoskel. S., NIH, Bethesda, MD, United States; Hennekam, R.C.M., Institute of Human Genetics, Department of Pediatrics, Amsterdam Medical College, Amsterdam, Netherlands; Baumbach, L.L., University of Miami, School of Medicine, Miami, FL, United States; Neville, H.E., University of Colorado, School of Medicine, Denver VA Medical Center, Denver, CO, United States; Garcia, C.A., Louisiana State University, School of Medicine, New Orleans, LA, United States; Klingman, J., Permanente Medical Group, Walnut Creek, CA, United States; Gibbs, M., Permanente Medical Group, Walnut Creek, CA, United States; Weisman, M.H., Univ. of California Medical Center, San Diego, CA, United States; Targoff, I.N., VA Medical Center, Univ. of Oklahoma Med. Sci. Center, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States; Miller, F.W., Ctr. for Biologics Eval. and Res., FDA, Natl. Inst. Arthr. Musculoskel. S., Bethesda, MD, United States
1998Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathyRider, L.G.; Gurley, R.C.; Pandey, J.P.; Garcia-De La Torre, I.; Kalovidouris, A.E.; O'Hanlon, T.P.; Love, L.A.; Hennekam, R.C.M.; Baumbach, L.L.; Neville, H.E.; Garcia, C.A.; Klingman, J.; Gibbs, M.; Weisman, M.H.; Targoff, I.N.; Miller, F.W.; Rider, L.G., Ctr. for Biologics Eval. and Res., FDA, Natl. Inst. Arthr. Musculoskel. S., Bethesda, MD, United States, Division of Monoclonal Antibodies, Ctr. for Biologies Eval. and Res., Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892, United States; Gurley, R.C., Ctr. for Biologics Eval. and Res., FDA, Bethesda, MD, United States; Pandey, J.P., Medical University of South Carolina, Charleston, SC, United States; Garcia-De La Torre, I., University of Guadalajara, Hosp. General de Occidente de la SS, Guadalajara, Mexico; Kalovidouris, A.E., Indiana University, VA Medical Center, Indianapolis, IN, United States; O'Hanlon, T.P., Ctr. for Biologics Eval. and Res., FDA, Bethesda, MD, United States; Love, L.A., Ctr. for Food and Spec. Nutritionals, FDA, Washington, DC, United States, Natl. Inst. Arthr. Musculoskel. S., NIH, Bethesda, MD, United States; Hennekam, R.C.M., Institute of Human Genetics, Department of Pediatrics, Amsterdam Medical College, Amsterdam, Netherlands; Baumbach, L.L., University of Miami, School of Medicine, Miami, FL, United States; Neville, H.E., University of Colorado, School of Medicine, Denver VA Medical Center, Denver, CO, United States; Garcia, C.A., Louisiana State University, School of Medicine, New Orleans, LA, United States; Klingman, J., Permanente Medical Group, Walnut Creek, CA, United States; Gibbs, M., Permanente Medical Group, Walnut Creek, CA, United States; Weisman, M.H., Univ. of California Medical Center, San Diego, CA, United States; Targoff, I.N., VA Medical Center, Univ. of Oklahoma Med. Sci. Center, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States; Miller, F.W., Ctr. for Biologics Eval. and Res., FDA, Natl. Inst. Arthr. Musculoskel. S., Bethesda, MD, United States
2002Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican mestizos and North American Caucasians: Ethnogeographic influences in the genetics and clinical expression of myositisShamim, E.A.; Rider, L.G.; Pandey, J.P.; O'Hanlon, T.P.; Jara, L.J.; Samayoa, E.A.; Burgos-Vargas, R.; Vazquez-Mellado, J.; Alcocer-Varela, J.; Salazar-Paramo, M.; Kutzbach, A.G.; Malley, J.D.; Targoff, I.N.; Garcia-De La Torre, I.; Miller, F.W.; Shamim, E.A., Center for Biologics Evaluation and Research, FDA, Bethesda, MD, United States, Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, 9 Memorial Drive, Bethesda, MD 20892-0958, United States; Rider, L.G., Center for Biologics Evaluation and Research, FDA, Bethesda, MD, United States; Pandey, J.P., Medical University of South Carolina, Charleston, SC, United States; O'Hanlon, T.P., Center for Biologics Evaluation and Research, FDA, Bethesda, MD, United States; Jara, L.J., Hospital de Especialidades Centro Medico la Raza, Mexico City, Mexico; Samayoa, E.A., Hospital General San Juan de Dios, San Juan de Dios, Guatemala; Burgos-Vargas, R., Universidad Nacional Autonoma de Mexico, Mexico City, Mexico; Vazquez-Mellado, J., Hospital General de Mexico, Mexico City, Mexico; Alcocer-Varela, J., Instituto Nacional de la Nutricion, Mexico City, Mexico; Salazar-Paramo, M., Unidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Especialidades, University of Guadalajara, Guadalajara, Mexico; Kutzbach, A.G., Universidad Francisco Marrequin, Guatamala City, Guatemala; Malley, J.D., Center for Information Technology, NIH, Bethesda, MD, United States; Targoff, I.N., Veterans Affairs Medical Center, University of Oklahoma Medical Sciences Center, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States; Garcia-De La Torre, I., Hospital General de Occidente de la Secretaria de Salud, University of Guadalajara, Guadalajara, Mexico; Miller, F.W., Center for Biologics Evaluation and Research, FDA, Bethesda, MD, United States
2002Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican mestizos and North American Caucasians: Ethnogeographic influences in the genetics and clinical expression of myositisShamim, E.A.; Rider, L.G.; Pandey, J.P.; O'Hanlon, T.P.; Jara, L.J.; Samayoa, E.A.; Burgos-Vargas, R.; Vazquez-Mellado, J.; Alcocer-Varela, J.; Salazar-Paramo, M.; Kutzbach, A.G.; Malley, J.D.; Targoff, I.N.; Garcia-De La Torre, I.; Miller, F.W.; Shamim, E.A., Center for Biologics Evaluation and Research, FDA, Bethesda, MD, United States, Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, 9 Memorial Drive, Bethesda, MD 20892-0958, United States; Rider, L.G., Center for Biologics Evaluation and Research, FDA, Bethesda, MD, United States; Pandey, J.P., Medical University of South Carolina, Charleston, SC, United States; O'Hanlon, T.P., Center for Biologics Evaluation and Research, FDA, Bethesda, MD, United States; Jara, L.J., Hospital de Especialidades Centro Medico la Raza, Mexico City, Mexico; Samayoa, E.A., Hospital General San Juan de Dios, San Juan de Dios, Guatemala; Burgos-Vargas, R., Universidad Nacional Autonoma de Mexico, Mexico City, Mexico; Vazquez-Mellado, J., Hospital General de Mexico, Mexico City, Mexico; Alcocer-Varela, J., Instituto Nacional de la Nutricion, Mexico City, Mexico; Salazar-Paramo, M., Unidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Especialidades, University of Guadalajara, Guadalajara, Mexico; Kutzbach, A.G., Universidad Francisco Marrequin, Guatamala City, Guatemala; Malley, J.D., Center for Information Technology, NIH, Bethesda, MD, United States; Targoff, I.N., Veterans Affairs Medical Center, University of Oklahoma Medical Sciences Center, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States; Garcia-De La Torre, I., Hospital General de Occidente de la Secretaria de Salud, University of Guadalajara, Guadalajara, Mexico; Miller, F.W., Center for Biologics Evaluation and Research, FDA, Bethesda, MD, United States
2000Factitious disorders mimicking systemic lupus erythematosusTlacuilo-Parra, J.A.; Guevara-Gutierrez, E.; Garcia-De La Torre, I.; Tlacuilo-Parra, J.A., Dept. of Immunology and Rheumatology, Hosp. Gen. Occidente Secretaria S., Guadalajara, Jalisco, Mexico, CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico; Guevara-Gutierrez, E., Department of Dermatology, Hosp. Gen. Occidente Secretaria S., Guadalajara, Jalisco, Mexico; Garcia-De La Torre, I., Dept. of Immunology and Rheumatology, Hosp. Gen. Occidente Secretaria S., Guadalajara, Jalisco, Mexico, CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico, Dept. of Immunology and Rheumatology, Hosp. Gen. Occidente Secretaria S., Avenida Zoquipan # 1050, C.P. 45170, Zapopan, Jalisco, Mexico
2000Factitious disorders mimicking systemic lupus erythematosusTlacuilo-Parra, J.A.; Guevara-Gutierrez, E.; Garcia-De La Torre, I.; Tlacuilo-Parra, J.A., Dept. of Immunology and Rheumatology, Hosp. Gen. Occidente Secretaria S., Guadalajara, Jalisco, Mexico, CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico; Guevara-Gutierrez, E., Department of Dermatology, Hosp. Gen. Occidente Secretaria S., Guadalajara, Jalisco, Mexico; Garcia-De La Torre, I., Dept. of Immunology and Rheumatology, Hosp. Gen. Occidente Secretaria S., Guadalajara, Jalisco, Mexico, CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico, Dept. of Immunology and Rheumatology, Hosp. Gen. Occidente Secretaria S., Avenida Zoquipan # 1050, C.P. 45170, Zapopan, Jalisco, Mexico
2009Gonococcal and Nongonococcal ArthritisGarcia-De La Torre, I.; Nava-Zavala, A.; García-De La Torre, I., Department of Immunology and Rheumatology, Hospital General de Occidente, Secretaría de Salud, Justo Sierra 2821, Guadalajara, México, CP 44690, Mexico, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Nava-Zavala, A., Department of Immunology and Rheumatology, Hospital General de Occidente, Secretaría de Salud, Justo Sierra 2821, Guadalajara, México, CP 44690, Mexico, Unidad de Investigación en Epidemiología Clínica, UMAE, HE, Jalisco, Mexico
2009Gonococcal and Nongonococcal ArthritisGarcia-De La Torre, I.; Nava-Zavala, A.; Garc�a-De La Torre, I., Department of Immunology and Rheumatology, Hospital General de Occidente, Secretar�a de Salud, Justo Sierra 2821, Guadalajara, M�xico, CP 44690, Mexico, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Nava-Zavala, A., Department of Immunology and Rheumatology, Hospital General de Occidente, Secretar�a de Salud, Justo Sierra 2821, Guadalajara, M�xico, CP 44690, Mexico, Unidad de Investigaci�n en Epidemiolog�a Cl�nica, UMAE, HE, Jalisco, Mexico
2009Idiopathic inflammatory myopathies [Miopatías inflamatorias idiopáticas]Andrade-Ortega, L.; Garcia-De La Torre, I.; Andrade-Ortega, L., Servicio de Reumatología, Centro Médico Nacional 20 de Noviembre, ISSSTE, México D.F., Mexico; García-De La Torre, I., Departamento de Inmunología y Reumatología, Hospital General de Occidente de la Secretaría de Salud, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, Mexico
2013Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in lupus nephritis among MexicansTopete-Reyes, J.F.; Soto-Vargas, J.; Moran-Moguel, M.C.; Davalos-Rodriguez, I.P.; Chavez-Gonzalez, E.L.; Garcia-De La Torre, I.; Parra-Michel, R.; Medina-Perez, M.; Jalomo-Martinez, B.; Salazar-Paramo, M.; Topete-Reyes, J.F., Doctorado en Inmunología, Departamento de Fisiología, CUCS, Universidad de Guadalajara, Guadalajara, Mexico, Departamento de Nefrología, Hospital General Regional 46, Instituto Mexicano del Seguro Social, Guadalajara, Mexico; Soto-Vargas, J., Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Mexico; Morán-Moguel, M.C., División de Genética, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Mexico, Doctorado de Genética Humana, CUCS, Universidad de Guadalajara, Guadalajara, Mexico; Dávalos-Rodríguez, I.P., División de Genética, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Mexico, Doctorado de Genética Humana, CUCS, Universidad de Guadalajara, Guadalajara, Mexico; Chávez-González, E.L., Doctorado en Farmacología, Departamento de Fisiología, CUCS, Universidad de Guadalajara, Guadalajara, Mexico; García-De La Torre, I., Departamento de Inmunología y Reumatología, Hospital General de Occidente, Secretaría de Salud, Zapopan, Jalisco, Mexico, Departamento de Fisiología, CUCS, Universidad de Guadalajara, Guadalajara, Mexico; Parra-Michel, R., Departamento de Nefrología, Hospital General Regional 46, Instituto Mexicano del Seguro Social, Guadalajara, Mexico; Medina-Pérez, M., Departamento de Nefrología, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Mexico; Jalomo-Martínez, B., Departamento de Nefrología, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Mexico; Salazar-Páramo, M., Departamento de Fisiología, CUCS, Universidad de Guadalajara, Guadalajara, Mexico, División de Investigación en Salud, Hospital de Especialidades, Instituto Mexicano del Seguro Social, Belisario Domínguez 1000, CP 43349 Guadalajara, Jal, Mexico
2006International multicenter evaluation of autoantibodies to ribosomal P proteinsMahler, M.; Kessenbrock, K.; Szmyrka, M.; Takasaki, Y.; Garcia-De La Torre, I.; Shoenfeld, Y.; Hiepe, F.; Shun-Le, C.; Von Muhlen, C.A.; Locht, H.; Hopfl, P.; Wiik, A.; Reeves, W.; Fritzler, M.J.; Mahler, M., Dr. Fooke Laboratorien GmbH, Neuss, Germany, Dr. Fooke Laboratorien GmbH, Mainstr. 85, 41469 Neuss, Germany; Kessenbrock, K., Department of Molecular Genetics, University of Heidelberg, Heidelberg, Germany; Szmyrka, M., Wroclaw University of Medicine, Wroclaw, Poland; Takasaki, Y., Division of Rheumatology, Department of Medicine, Jutendo University, Tokyo, Japan; Garcia-De La Torre, I., University of Guadalajara, Guadalajara, Mexico; Shoenfeld, Y., Sheba Medical Center, Tel Aviv, Israel; Hiepe, F., Charite Humboldt University, Berlin, Germany; Shun-Le, C., Shanghai Medical University, Shanghai, China; Von Mühlen, C.A., Pontifical Catholic University School of Medicine, Porto Allegre, Brazil; Locht, H., Statens Serum Institute, Copenhagen, Denmark; Höpfl, P., Sweden Diagnostics Deutschland GmbH, Freiburg, Germany; Wiik, A., Statens Serum Institute, Copenhagen, Denmark; Reeves, W., University of Florida, Gainesville, FL, United States; Fritzler, M.J., University of Calgary, Calgary, Alta., Canada
2006International multicenter evaluation of autoantibodies to ribosomal P proteinsMahler, M.; Kessenbrock, K.; Szmyrka, M.; Takasaki, Y.; Garcia-De La Torre, I.; Shoenfeld, Y.; Hiepe, F.; Shun-Le, C.; Von Muhlen, C.A.; Locht, H.; Hopfl, P.; Wiik, A.; Reeves, W.; Fritzler, M.J.; Mahler, M., Dr. Fooke Laboratorien GmbH, Neuss, Germany, Dr. Fooke Laboratorien GmbH, Mainstr. 85, 41469 Neuss, Germany; Kessenbrock, K., Department of Molecular Genetics, University of Heidelberg, Heidelberg, Germany; Szmyrka, M., Wroclaw University of Medicine, Wroclaw, Poland; Takasaki, Y., Division of Rheumatology, Department of Medicine, Jutendo University, Tokyo, Japan; Garcia-De La Torre, I., University of Guadalajara, Guadalajara, Mexico; Shoenfeld, Y., Sheba Medical Center, Tel Aviv, Israel; Hiepe, F., Charite Humboldt University, Berlin, Germany; Shun-Le, C., Shanghai Medical University, Shanghai, China; Von Muhlen, C.A., Pontifical Catholic University School of Medicine, Porto Allegre, Brazil; Locht, H., Statens Serum Institute, Copenhagen, Denmark; H pfl, P., Sweden Diagnostics Deutschland GmbH, Freiburg, Germany; Wiik, A., Statens Serum Institute, Copenhagen, Denmark; Reeves, W., University of Florida, Gainesville, FL, United States; Fritzler, M.J., University of Calgary, Calgary, Alta., Canada
2014International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodiesAgmon-Levin, N.; Damoiseaux, J.; Kallenberg, C.; Sack, U.; Witte, T.; Herold, M.; Bossuyt, X.; Musset, L.; Cervera, R.; Plaza-Lopez, A.; Dias, C.; Jose Sousa, M.; Radice, A.; Eriksson, C.; Hultgren, O.; Viander, M.; Khamashta, M.; Regenass, S.; Coelho Andrade, L.E.; Wiik, A.; Tincani, A.; Ronnelid, J.; Bloch, D.B.; Fritzler, M.J.; Chan, E.K.L.; Garcia-De La Torre, I.; Konstantinov, K.N.; Lahita, R.; Wilson, M.; Vainio, O.; Fabien, N.; Sinico, R.A.; Meroni, P.; Shoenfeld, Y.; Agmon-Levin, N., Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer 52621, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; Damoiseaux, J., Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, Netherlands; Kallenberg, C., Department of Rheumatology and Clinical Immunology, University of Groningen, Groningen, Netherlands; Sack, U., University Leipzig, Institute for Clinical Immunology and Transfusion Medicine, Leipzig, Germany; Witte, T., Department of Clinic for Immunology and Rheumatology, Medical School, Hanover, Germany; Herold, M., Department of Internal Medicine 1, Rheumatology Unit, Innsbruck Medical University, Innsbruck, Austria, Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium; Bossuyt, X., Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Musset, L., Immunology Department, GH Pitie-Salpêtriere, Paris, France; Cervera, R., Department of Autoimmune Diseases, Hospital Clínic Barcelona, Catalonia, Spain; Plaza-Lopez, A., Servicio de Inmunología, Hospital Universitario Pueta de Hierro, Majadahonda, Madrid, Spain; Dias, C., Autoimmune Diseases Unit, Medicine Department, S. João Hospital, Porto, Portugal; José Sousa, M., Autoimmunity and PreNatal Diagnostic Laboratory Unit, Fernando Fonseca Hospital, Porto, Portugal; Radice, A., Institute of Microbiology, Azienda Ospedaliera Ospedale San Carlo Borromeo, Milano, Italy; Eriksson, C., Department of Clinical Microbiology, Clinical Immunology, Umeå University, Umeå, Sweden; Hultgren, O., Department of Laboratory Medicine, Clinical Immunology, University Hospital of Orebro, Orebro University, Orebro, Sweden; Viander, M., Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland; Khamashta, M., Lupus Research Laboratory, Division of Women's Health, King's College London, London, United Kingdom; Regenass, S., Klinik für Immunologie, DIA UniversitätsSpital, Zürich, Switzerland; Coelho Andrade, L.E., Rheumatology Division, Universidade Federal de São Paulo', Sao Paulo, Brazil; Wiik, A., Department of Clinical Chemistry and Immunology, Statens Serum Institut, Copenhagen S, Denmark; Tincani, A., Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Science, University of Brescia, Brescia, Italy; Rönnelid, J., Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Bloch, D.B., Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Harvard, MA, United States; Fritzler, M.J., Faculty of Medicine, University of Calgary, Calgary, AB, Canada; Chan, E.K.L., Department of Oral Biology, University of Florida, Gainesville, FL, United States; Garcia-De La Torre, I., Department Immunology and Rheumatology, Hospital General de Occidente, University of Guadalajara, Guadalajara, Jal, Mexico; Konstantinov, K.N., Medicine/Rheumatology, UNM School of Medicine, NM, United States; Lahita, R., Medicine and VP, Newark Beth Israel Medical Center UMDNJ, Newark, United States; Wilson, M., LSU School of Medicine, United States; Vainio, O., Department of Medical Microbiology and Immunology, Institute of Diagnostics, University of Oulu, Oulu, Finland; Fabien, N., Department of Immunology, CH Lyon Sud, Pierre-Benite, France; Sinico, R.A., Clinical Immunology Unit, Renal Unit, Azienda Ospedaliera Ospedale San Carlo Borromeo, Milano, Italy; Meroni, P., Division of Rheumatology, Istituto Auxologico Italiano, University of Milan, Milan, Italy; Shoenfeld, Y., Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer 52621, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel, Sackler Faculty of Medicine, Incumbent of the Laura Schwarz-Kip Department for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Aviv, Israel
2014International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodiesAgmon-Levin, N.; Damoiseaux, J.; Kallenberg, C.; Sack, U.; Witte, T.; Herold, M.; Bossuyt, X.; Musset, L.; Cervera, R.; Plaza-Lopez, A.; Dias, C.; Jose Sousa, M.; Radice, A.; Eriksson, C.; Hultgren, O.; Viander, M.; Khamashta, M.; Regenass, S.; Coelho Andrade, L.E.; Wiik, A.; Tincani, A.; Ronnelid, J.; Bloch, D.B.; Fritzler, M.J.; Chan, E.K.L.; Garcia-De La Torre, I.; Konstantinov, K.N.; Lahita, R.; Wilson, M.; Vainio, O.; Fabien, N.; Sinico, R.A.; Meroni, P.; Shoenfeld, Y.; Agmon-Levin, N., Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer 52621, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; Damoiseaux, J., Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, Netherlands; Kallenberg, C., Department of Rheumatology and Clinical Immunology, University of Groningen, Groningen, Netherlands; Sack, U., University Leipzig, Institute for Clinical Immunology and Transfusion Medicine, Leipzig, Germany; Witte, T., Department of Clinic for Immunology and Rheumatology, Medical School, Hanover, Germany; Herold, M., Department of Internal Medicine 1, Rheumatology Unit, Innsbruck Medical University, Innsbruck, Austria, Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium; Bossuyt, X., Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Musset, L., Immunology Department, GH Pitie-Salp�triere, Paris, France; Cervera, R., Department of Autoimmune Diseases, Hospital Cl�nic Barcelona, Catalonia, Spain; Plaza-Lopez, A., Servicio de Inmunolog�a, Hospital Universitario Pueta de Hierro, Majadahonda, Madrid, Spain; Dias, C., Autoimmune Diseases Unit, Medicine Department, S. Jo�o Hospital, Porto, Portugal; Jos� Sousa, M., Autoimmunity and PreNatal Diagnostic Laboratory Unit, Fernando Fonseca Hospital, Porto, Portugal; Radice, A., Institute of Microbiology, Azienda Ospedaliera Ospedale San Carlo Borromeo, Milano, Italy; Eriksson, C., Department of Clinical Microbiology, Clinical Immunology, Ume� University, Ume�, Sweden; Hultgren, O., Department of Laboratory Medicine, Clinical Immunology, University Hospital of Orebro, Orebro University, Orebro, Sweden; Viander, M., Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland; Khamashta, M., Lupus Research Laboratory, Division of Women's Health, King's College London, London, United Kingdom; Regenass, S., Klinik f�r Immunologie, DIA Universit�tsSpital, Z�rich, Switzerland; Coelho Andrade, L.E., Rheumatology Division, Universidade Federal de S�o Paulo', Sao Paulo, Brazil; Wiik, A., Department of Clinical Chemistry and Immunology, Statens Serum Institut, Copenhagen S, Denmark; Tincani, A., Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Science, University of Brescia, Brescia, Italy; R�nnelid, J., Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Bloch, D.B., Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Harvard, MA, United States; Fritzler, M.J., Faculty of Medicine, University of Calgary, Calgary, AB, Canada; Chan, E.K.L., Department of Oral Biology, University of Florida, Gainesville, FL, United States; Garcia-De La Torre, I., Department Immunology and Rheumatology, Hospital General de Occidente, University of Guadalajara, Guadalajara, Jal, Mexico; Konstantinov, K.N., Medicine/Rheumatology, UNM School of Medicine, NM, United States; Lahita, R., Medicine and VP, Newark Beth Israel Medical Center UMDNJ, Newark, United States; Wilson, M., LSU School of Medicine, United States; Vainio, O., Department of Medical Microbiology and Immunology, Institute of Diagnostics, University of Oulu, Oulu, Finland; Fabien, N., Department of Immunology, CH Lyon Sud, Pierre-Benite, France; Sinico, R.A., Clinical Immunology Unit, Renal Unit, Azienda Ospedaliera Ospedale San Carlo Borromeo, Milano, Italy; Meroni, P., Division of Rheumatology, Istituto Auxologico Italiano, University of Milan, Milan, Italy; Shoenfeld, Y., Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer 52621, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel, Sackler Faculty of Medicine, Incumbent of the Laura Schwarz-Kip Department for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Aviv, Israel
2009Laboratory abnormalities and autoantibodies [Alteraciones de laboratorio y autoanticuerpos]Garcia-De La Torre, I.; Garcia-Valladares, I.; García-De La Torre, I., Departamento de Inmunología y Reumatología, Hospital General de Occidente de la Secretaría de Salud, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; García-Valladares, I., Departamento de Medicina Interna, Hospital Civil Juan I. Menchaca, Guadalajara, Jalisco, Mexico
2002Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndromeSalazar-Paramo, M.; Jara, L.J.; Ramos, A.; Barile, L.; Machado, G.; Garcia-De La Torre, I.; Salazar-P�ramo, M., Clinical Epidemiology Research Unit, Hospital de Especialidades, Universidad de Guadalajara, Guadalajara, Mexico; Jara, L.J., Department of Rheumatology, Hospital de Especialidades, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Ramos, A., Department of Rheumatology, Hospital de Especialidades, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Barile, L., Department of Rheumatology, Hospital de Especialidades, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Machado, G., Justo Sierra 2821, Col. Vallarta Norte, Guadalajara, Jal. C.P. 44690, Mexico; Garc�a-De La Torre, I., Department of Immunology and Rheumatology, Hospital General de Occidente de la Secretar�a de Salud, Universidad de Guadalajara, Guadalajara, Mexico